Key result
Quercetin reduced SERCA1a activity by 48% at 250 μM, while its derivative CHNQ significantly reduced activity by 94% at 250 μM through global protein structure changes.
Why the study?
SERCAs regulate cellular calcium homeostasis and are targeted for age-related diseases, prompting investigation into how quercetin derivatives affect SERCA1a.
Quercetin and its novel derivatives inhibit SERCA1a activity through distinct mechanisms, with CHNQ causing extensive impairment of the enzyme's conformation.
Sarcoplasmic reticulum Ca2+-ATPases (SERCAs) regulate cellular calcium homeostasis and are targeted for age-related diseases. Among 14 SERCA mRNA splice variants, SERCA1a is specific to adult fast-twitch skeletal muscle. Quercetin derivatives (monochloropivaloylquercetin (CPQ), IC50 = 195.7 µM; 2-chloro-1,4-naphthoquinonequercetin (CHNQ), IC50 = 60.3 µM) were studied for their impact on SERCA1a using molecular modeling and enzyme kinetics. While there were some similarities in kinetic parameters and molecular modeling, the compounds exhibited diverse actions on SERCA1a. Quercetin reduced activity by 48% at 250 μM by binding to the cytosolic ATP-binding pocket with increased ATP affinity. CPQ bound near the Ca2+-binding site, possibly altering the transmembrane domain. CHNQ significantly reduced activity by 94% at 250 μM without binding to substrate sites. It was proposed that CHNQ induced global protein structure changes, inhibiting Ca2+-ATPase activity.
No takes yet. Share an insight, caveat, or question.
Rezbáriková et al. (2023) studied this question. Quercetin and its derivatives (CPQ, CHNQ) vs. Control (no flavonoid) was evaluated on SERCA1a activity. Quercetin reduced SERCA1a activity by 48% at 250 μM, while its derivative CHNQ significantly reduced activity by 94% at 250 μM through global protein structure changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: